These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26748233)

  • 1. Antiretroviral drugs saquinavir and ritonavir reduce inhibitory concentration values of itraconazole against Histoplasma capsulatum strains in vitro.
    Brilhante RS; Caetano ÉP; Riello GB; Guedes GM; Castelo-Branco Dde S; Fechine MA; Oliveira JS; Camargo ZP; Mesquita JR; Monteiro AJ; Cordeiro Rde A; Rocha MF; Sidrim JJ
    Braz J Infect Dis; 2016; 20(2):155-9. PubMed ID: 26748233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.
    de Aguiar Cordeiro R; de Farias Marques FJ; de Aguiar Cordeiro R; da Silva MR; Donato Maia Malaquias A; Silva de Melo CV; Mafezoli J; Ferreira de Oliveira Mda C; Nogueira Brilhante RS; Gadelha Rocha MF; Pinheiro Gomes Bandeira Tde J; Costa Sidrim JJ
    Antimicrob Agents Chemother; 2014 May; 58(5):2504-11. PubMed ID: 24514090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavir.
    Hills-Nieminen C; Hughes CA; Houston S; Shafran SD
    Ann Pharmacother; 2009 Dec; 43(12):2117-20. PubMed ID: 19934385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp.
    Brilhante RS; Malaquias AD; Caetano EP; Castelo-Branco Dde S; Lima RA; Marques FJ; Silva NF; Alencar LP; Monteiro AJ; Camargo ZP; Bandeira Tde J; Rodrigues AM; Cordeiro Rde A; Moreira JL; Sidrim JJ; Rocha MF
    Med Mycol; 2014 Apr; 52(3):320-5. PubMed ID: 24662247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saquinavir potentiates itraconazole's antifungal activity against multidrug-resistant Candida auris in vitro andin vivo.
    Elgammal Y; Salama EA; Seleem MN
    Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37558393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
    Skinner-Adams TS; Andrews KT; Melville L; McCarthy J; Gardiner DL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):759-62. PubMed ID: 17088482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
    Blanco MT; Hurtado C; Pérez-Giraldo C; Morán FJ; González-Velasco C; Gómez-García AC
    Med Mycol; 2003 Apr; 41(2):167-70. PubMed ID: 12964850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
    Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.
    Crommentuyn KM; Mulder JW; Sparidans RW; Huitema AD; Schellens JH; Beijnen JH
    Clin Infect Dis; 2004 Apr; 38(8):e73-5. PubMed ID: 15095234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir.
    Koks CH; van Heeswijk RP; Veldkamp AI; Meenhorst PL; Mulder JW; van der Meer JT; Beijnen JH; Hoetelmans RM
    AIDS; 2000 Jan; 14(1):89-90. PubMed ID: 10714572
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients.
    Valer L; de Mendoza C; Soriano V
    J Med Virol; 2005 Dec; 77(4):460-4. PubMed ID: 16254964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi.
    Brilhante RS; Caetano EP; Lima RA; Castelo Branco DS; Serpa R; Oliveira JS; Monteiro AJ; Rocha MF; Cordeiro RA; Sidrim JJ
    J Appl Microbiol; 2015 Oct; 119(4):962-9. PubMed ID: 26178247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
    Migliorati CA; Birman EG; Cury AE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.